GE HealthCare Technologies Inc
Research GE HealthCare Technologies Inc (GEHC) on Bullrun: valuation model: 20.1% undervalued, market cap USD 30.60B, P/E 15.6, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGEHC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal20.1% undervalued
- Market capUSD 30.60B
- P/E15.6
- Dividend yield0.2%
- Financial periodQ2 2026
- RevenueUSD 5.29B
- Net incomeUSD 560.00M
- Free cash flowUSD 68.00M
- Gross margin41.2%
Valuation Snapshot
Bullrun's latest valuation model marks GE HealthCare Technologies Inc as 20.1% undervalued; latest market cap is USD 30.60B; P/E is 15.6; dividend yield is 0.2%.
Peer valuation comparison
Latest P/E is 15.57x versus a Healthcare sector median of 24.6x (36.7% below).
Latest dividend yield is 0.21% versus a Healthcare sector median of 1.84% (88.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 20.63B | USD 2.08B | USD 1.51B | 40.0% | 4.55 | USD 4.49B | USD 10.00B | USD 10.38B |
| FY2024 | USD 19.67B | USD 1.99B | USD 1.55B | 41.7% | 4.34 | USD 2.87B | USD 8.95B | USD 8.45B |
| FY2023 | USD 19.55B | USD 1.57B | USD 1.71B | 40.5% | 3.03 | USD 2.49B | USD 9.44B | USD 7.13B |
| FY2022 | USD 18.34B | USD 1.92B | USD 1.82B | 39.1% | 4.22 | USD 1.44B | USD 8.24B | USD 9.36B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 30.60B | 15.6 | 0.2% | 0.15 |
| 2025 | 2025-12-31 | USD 37.38B | 18.0 | 0.2% | 0.16 |
| 2024 | 2024-12-31 | USD 35.72B | 18.0 | 0.2% | 0.12 |
| 2023 | 2023-12-29 | USD 35.20B | 22.9 | 0.1% | 0.09 |
| 2022 | 2022-12-30 | USD 26.55B | 13.8 | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.15 USD, yield 0.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.14 USD |
| FY2024 | 0.13 USD |
| FY2023 | 0.12 USD |
About GE HealthCare Technologies Inc
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
ETFs that hold GE HealthCare Technologies Inc
GE HealthCare Technologies Inc is one of the ten largest holdings of one ETF that investors in Europe can buy:
| ETF | Weight | TER |
|---|---|---|
| Nasdaq 100 Daily Covered Call UCITS ETF USD Distributing | 9.41% | 0.59% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is GE HealthCare Technologies Inc overvalued or undervalued?
Bullrun's valuation model currently marks GE HealthCare Technologies Inc as 20.1% undervalued.
What is GE HealthCare Technologies Inc's market cap?
GE HealthCare Technologies Inc's market capitalization is USD 30.60B.
What is GE HealthCare Technologies Inc's P/E ratio?
GE HealthCare Technologies Inc's price-to-earnings (P/E) ratio is 15.6.
Does GE HealthCare Technologies Inc pay a dividend?
GE HealthCare Technologies Inc has a dividend yield of 0.2%.
What does GE HealthCare Technologies Inc do?
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products.